After completing this activity, pharmacists should be able to:
- Outline the reasons for compounding a medicine including legislative implications, the reasons for modifying commercially available products and advising patients about the need to compound.
- Describe the important pharmaceutical considerations of compounding using powders including particle size, bulk density, blending, geometric dilution and trituration and the processes used to optimise these when compounding a medicine.
- Undertake a risk assessment in preparation for compounding a medicine.
- Determine beyond use dates for compounded medicines.
- Complete a batch sheet for compounded medicines, including the audit trail for raw ingredients, and dispense the prescription.
- Describe quality assurance and quality improvement considerations for compounded medicines.
- Describe strategies to prevent errors occurring when compounding medicines.
- List resources and references that contain pertinent information to support pharmacists compounding of medicines.
- Counsel patients on the use and storage of medicines, including the provision of written information, follow-up and reporting of adverse events.
The 2010 Competency Standards addressed by this activity include: 1.1, 1.2, 1.3, 1.4, 2.1, 3.3, 3.4, 3.5, 4.1, 4.2, 4.3, 5.1, 5.2
The 2016 Competency Standards addressed by this activity include: 1.1, 1.2, 1.3, 1.6, 2.3, 3.2, 3.4, 4.5, 4.7
Accreditation number: A1802FAGR1 Accreditation expires: 01/03/2020
This activity has been accredited for 1.0 hour of Group One CPD (or 1.0 CPD credit) suitable for inclusion in an individual pharmacist’s CPD plan, which may be converted to 1.0 hour of Group Two CPD (or 2.0 CPD credits) upon successful completion of the associated assessment activity.